Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Best

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trialJohn Furler, David O'Neal, Jane Speight, et al.
The Lancet. Diabetes & Endocrinology|September 1, 2024
Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in SingaporeTheresia Mina, Wubin Xie, Dorrain Yanwen Low, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Nuclear regulatory disturbances precede and predict the development of Type-2 diabetes in Asian populationsPritesh R Jain, Hong Kiat Ng, Darwin Tay, et al.
Nature Cardiovascular Research|May 13, 2025
Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populationsNilanjana Sadhu, Rinkoo Dalan, Pritesh R Jain, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
The Lancet. Diabetes & Endocrinology|December 22, 2019
Use of professional-mode flash glucose monitoring, at 3-month intervals, in adults with type 2 diabetes in general practice (GP-OSMOTIC): a pragmatic, open-label, 12-month, randomised controlled trialJohn Furler, David O'Neal, Jane Speight, et al.
The Lancet. Diabetes & Endocrinology|September 1, 2024
Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in SingaporeTheresia Mina, Wubin Xie, Dorrain Yanwen Low, et al.
Medrxiv : the Preprint Server for Health Sciences|February 24, 2025
Nuclear regulatory disturbances precede and predict the development of Type-2 diabetes in Asian populationsPritesh R Jain, Hong Kiat Ng, Darwin Tay, et al.
Nature Cardiovascular Research|May 13, 2025
Metabolome-wide association identifies ferredoxin-1 (FDX1) as a determinant of cholesterol metabolism and cardiovascular risk in Asian populationsNilanjana Sadhu, Rinkoo Dalan, Pritesh R Jain, et al.
Pageof 5